Clinical trial
Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
NCT00537732 is registered in ClinicalTrials.gov with Matthias Schwab as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
- Lead sponsor
- Matthias Schwab
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2007
- Completion date
- December 31, 2010
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.